IndoStar Capital Q3 results: PAT Rs 825 lakh; Rs 1,176 cr exceptional gain in 9M

Exceptional ItemRevenue DeclineResults View source PDF Explain this filing

INDOSTAR · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+6.9%Reaction day

₹215.16

prior close

₹220.00

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+2.6%+4.3% vs market

Non Banking Financial Company (NBFC) peers, median of 206sector+0.5%+6.4% vs sector

On the reaction day the stock moved 4.3 pts more than Nifty Microcap 250 and 6.4 pts more than its Non Banking Financial Company (NBFC) peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.6

10m

-1.8

15m

-0.7

30m

-0.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+6.9+2.6+4.3+0.5+6.4

Next day

+5.5+3.6+1.9+0.7+4.8

+10.2+3.1+7.1+0.7+9.5

+12.8+2.6+10.3+0.2+12.6

+6.0+1.1+4.9-0.1+6.1

+6.9+0.3+6.6-0.7+7.6

+9.4+1.6+7.8-0.6+10.0

15d

+1.2-3.9+5.1-4.7+5.9

-3.8-8.1+4.3-7.4+3.6

+0.2-3.1+3.2-5.0+5.2

-1.1+9.2-10.2+0.1-1.2

UpDownMarket · Nifty Microcap 250Sector · Non Banking Financial Company (NBFC) peers, median of 206Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

IndoStar Capital Finance reported Q3 FY26 standalone PAT of Rs 825 lakh, down from Rs 1,141 lakh YoY, on revenue of Rs 346 crore. For 9M FY26, PAT surged to Rs 554 crore from Rs 40 crore, boosted by a one-time exceptional gain of Rs 1,176 crore from sale of subsidiary Niwas Housing Finance to WITKOPEEND B.V. Q3 finance costs fell to Rs 137 crore from Rs 193 crore, while impairment on financial instruments rose to Rs 77 crore from Rs 48 crore. Capital adequacy remains strong at 41.4 percent.

Likely market impact

Core Q3 earnings weak on lower revenue and higher impairments; exceptional gain from subsidiary sale already booked in 9M and non-recurring.